The national base medicine is about to be adjusted! Level 4 pharmaceutical will determine the life and death of the drug.

On February 26, the National Health and Health Commission and other six departments jointly issued the "Notice on the issue of the issue of strengthening the management of medical institutions to promote the promotion ofrational drug use" (National Health Medical Development (2020) No2) (referred to as No2) (referred to as the medical institutions, drug management and pharmaceutical services, increase the reform of drug use, the whole chain to promote drug reform, improve the management level of medical institutions, promote rational drug useIn this Notice, the health and health administrative departments are explicitly required to set up national, provincial and municipal pharmaceutical management and pharmacology committees, respectively, to provide technical support for national and regional pharmaceutical management and pharmacology servicesAt the same time, the document requires that the municipal level and above the health and health administrative departments set up a pool of pharmacist expertsThe Pharmaceutical Management and Pharmacology Committee of medical institutions shall, under the guidance of the administrative department of health and health, randomly select a certain number of pharmaceutical experts from the pool of pharmacists to participate in the determination of the procurement catalogue and procurement work, and increase the weight of the opinions of pharmaceutical expertsmore than three months apart, recently, a supporting document on the 2nd document - "The National Health and Health Administration Office on the issue of strengthening the management of medical institutions to promote rational drug use of the mission division of labor program notice" (State Health Office Medical Letter (2020) No419) officially surfacedDocument 419 from six aspects of the various aspects of the various tasks of the detailed arrangement, which is very clear is: the national base drug will be dynamic adjustment, drug centralized procurement will be more and more standardized unity, the fourth level of drug affairs will directly determine the life and death of drug procurementthe dynamic adjustment of national base drugs
document 419 once again stressed that the national base drug will be dynamically adjustedIt is worth mentioning that No2 and No419, in the regulation of medical institutions drug catalog, are unanimously mentioned: "standard medical institutions do medicine catalog." Medical institutions shall optimize the catalogue of drug use of this institution in a timely manner in accordance with the principles of safe, effective and economical drug use and the characteristics of disease treatment in this institutionThe country is guided by the demand for clinical drug use and dynamically adjusts the national list of essential drugs." As long as the medical institutions to achieve a stable and wide coverage of the drug catalog, clinical value, short-term effectiveness, long-term breakthrough, then into the national base medicine is in fact water into the canal Otherwise, expect market access personnel to temporarily hold Buddha feet, everywhere to find experts, or the provinces to find the main committee, expect to tick the time, will be very passive In accordance with the relevant policies, the relevant parties are gradually establishing a dynamic adjustment mechanism for the national catalogue of essential drugs, regularly carrying out evaluation of the catalogue, implementing dynamic adjustments, and the adjustment cycle in principle does not exceed three years The transfer process may be initiated in due course for newly approved and listed drugs with significant improvements in efficacy and reasonable prices According to this cycle calculation, the new national base medicine catalog will have to be released by next year at the latest At present, the implementation of the ground of the base drug in various places has begun one after another It is understood that Chongqing Has begun to fully implement, and not long ago Shandong Provincial Health And Health Commission also issued a notice from May 2020, divided into the formulation of programs, start implementation, effectiveness assessment, summary and promotion of the implementation of the national basic drug system integrated pilot Medical institutions at all levels are required to fully equip and give priority to the use of essential drugs, forming a model of 1 plus x drug use dominated by the base drug because health insurance fees are a prerequisite and a political task In order to achieve health insurance fees, ministries and local departments are also working in the following direction: 1) price reduction National picks (over-rated 3 or 1 plus 2), provincial belt belt budget procurement (over-rated less than 3 plus large purchase amount, high amount), GPO alliance, Sanming alliance, pilot city tender procurement 2) Limit the number of drug use, develop drug ratio indicators and clinical pathways; 3) strict supervision, supervision chain extended to the doctor's prescription drug centralized procurement will be more standardized and unified
because document 419 is issued by the Health and Care Commission Office, therefore, for the centralized procurement of drugs, more from the point of view of the use of the end, from the perspective of rational drug use Including "medical institutions should adhere to clinical needs-oriented, adhere to rational drug use, strict implementation of the general name prescription provisions" (reasonable use of drugs) Public medical institutions should earnestly implement the requirements for centralized procurement of medicines at the national and provincial levels, do a good job in the centralized procurement and use of drugs (implement procurement and use), rely on the provincial drug centralized procurement platform, and actively participate in the construction of a unified and open national public procurement market for medicines (from the point of view of the purchaser, providing relevant information does not mean that the right of tender procurement returns to medical institutions) Medical unions are encouraged to explore uniform drug procurement (using end-to-end to maintain drug convergence) level IV pharmaceutical affairs will decide the right to life and death of drug procurement
according to the requirements of documents No 2 and document 419, the municipal level and above the health administration departments set up a pool of pharmacistexperts The Pharmaceutical Management and Pharmacology Committee of medical institutions shall, under the guidance of the administrative department of health and health, randomly select a certain number of pharmaceutical experts from the pool of pharmacists to participate in the determination of the procurement catalogue and procurement work, and increase the weight of the opinions of pharmaceutical experts The administrative department of health and health has set up national, provincial and municipal pharmaceutical management and pharmacology committees to provide technical support for pharmaceutical management and pharmacology services in the whole country and the region Encourage conditional regions to establish a system of general pharmacists and integrate the chief pharmacist into the pharmacist's pool of experts. combined with the relevant contents of No 2 and Article 419, we can judge that the next step involves a general framework of drug access, that is, based on the background of the construction of the medical community, from the national, provincial, local and municipal levels to medical institutions, will be based on the existing, the establishment, supplement, optimization, improvement of the relevant structure and functions of the Pharmaceutical Management and Pharmacology Committee, thereby strengthening the unified management of pharmaceutical services Through the continuous construction of the medical union, through the procurement catalog unified this breakthrough, to achieve a seamless interface of the clinical procurement channel of drugs However, from the present point of view, there are many urgent problems to be solved in rational drug use, including the lack of clinical pharmacy awareness, pharmacy management and professional team need stoicism Prescription audit, drug treatment program development, comprehensive drug evaluation, clinical drug guidance is still an urgent need to solve the problem. For production enterprises, in the face of the new related levels of pharmaceutical events, market access functionwill will undoubtedly become more challenging, the formulation of drug procurement catalog will be to get rid of the relatively single formulation of reporting situation, become more complex and uncertain